XML 18 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Revenue $ 5,669 $ 3,862
Operating expenses:    
Cost of goods sold (exclusive of depreciation and amortization) 10,777 12,743
Research and development 16,242 19,503
Selling, general and administrative 33,510 30,324
Depreciation and amortization 5,238 4,821
Total operating expenses 65,767 67,391
Operating loss (60,098) (63,529)
Other income (expense):    
Interest expense, net (9,401) (3,664)
Change in fair value of warrants (33,177) (4,101)
Other income (loss), net 970 (220)
Loss before income taxes (101,706) (71,514)
Provision for income taxes 173 221
Net loss (101,879) (71,735)
Foreign currency translation adjustment (1,533) 827
Comprehensive loss (103,412) (70,908)
Net loss (101,879) (71,735)
Net loss attributable to common stockholders $ (101,879) $ (71,735)
Weighted average of shares outstanding – basic (in shares) 121,500 107,972
Weighted average of shares outstanding – diluted (in shares) 121,500 107,972
Net loss attributable to common stockholder per share – basic (in Dollars per share) $ (0.84) $ (0.66)
Net loss attributable to common stockholder per share – diluted (in Dollars per share) $ (0.84) $ (0.66)